| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Mishal Qubad, Robert A Bittne. Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia. Therapeutic advances in psychopharmacology. vol 13. 2023-03-30. PMID:36994117. |
second to none: rationale, timing, and clinical management of clozapine use in schizophrenia. |
2023-03-30 |
2023-08-14 |
Not clear |
| Mishal Qubad, Robert A Bittne. Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia. Therapeutic advances in psychopharmacology. vol 13. 2023-03-30. PMID:36994117. |
this narrative review summarizes all clinically relevant areas of evidence, which support clozapine's wide-ranging superior efficacy - for treatment-resistant schizophrenia (trs) and beyond - and make its safe use eminently feasible. |
2023-03-30 |
2023-08-14 |
Not clear |
| Mishal Qubad, Robert A Bittne. Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia. Therapeutic advances in psychopharmacology. vol 13. 2023-03-30. PMID:36994117. |
converging evidence indicates that trs constitutes a distinct albeit heterogeneous subgroup of schizophrenias primarily responsive to clozapine. |
2023-03-30 |
2023-08-14 |
Not clear |
| David Kitche. Author's Reply. RE: Routine clozapine assay monitoring to improve the management of treatment-resistant schizophrenia. BJPsych bulletin. vol 47. issue 2. 2023-03-30. PMID:36994680. |
re: routine clozapine assay monitoring to improve the management of treatment-resistant schizophrenia. |
2023-03-30 |
2023-08-14 |
Not clear |
| Sumeet Gupta, Liyana Nur Mohama. RE: Routine clozapine assay monitoring to improve the management of treatment-resistant schizophrenia. BJPsych bulletin. vol 47. issue 2. 2023-03-30. PMID:36994683. |
re: routine clozapine assay monitoring to improve the management of treatment-resistant schizophrenia. |
2023-03-30 |
2023-08-14 |
Not clear |
| Marcin Siwek, Adrian Andrzej Chrobak, Aleksandra Gorostowicz, Patrycja Król, Dominika Dude. Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review. Brain sciences. vol 13. issue 3. 2023-03-29. PMID:36979255. |
the aim of our study was to evaluate the effectiveness of lurasidone augmentation of clozapine in treatment-resistant schizophrenia (sz) in a retrospective chart review. |
2023-03-29 |
2023-08-14 |
Not clear |
| Myung A Lee, Philip Cola, Karu Jayathilake, Herbert Y Meltze. Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia. Journal of clinical psychopharmacology. 2023-03-28. PMID:36975722. |
long-term outcome of clozapine in treatment-resistant schizophrenia. |
2023-03-28 |
2023-08-14 |
Not clear |
| Myung A Lee, Philip Cola, Karu Jayathilake, Herbert Y Meltze. Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia. Journal of clinical psychopharmacology. 2023-03-28. PMID:36975722. |
the favorable effect of clozapine on psychotic symptoms in patients with treatment-resistant (tr) schizophrenia (scz) in short-term studies is well established. |
2023-03-28 |
2023-08-14 |
Not clear |
| Haruna Matsuzaki, Masakazu Hatano, Miko Iwata, Takeo Saito, Shigeki Yamad. Effectiveness of Clozapine on Employment Outcomes in Treatment-Resistant Schizophrenia: A Retrospective Bidirectional Mirror-Image Study. Neuropsychiatric disease and treatment. vol 19. 2023-03-22. PMID:36945253. |
effectiveness of clozapine on employment outcomes in treatment-resistant schizophrenia: a retrospective bidirectional mirror-image study. |
2023-03-22 |
2023-08-14 |
Not clear |
| Haruna Matsuzaki, Masakazu Hatano, Miko Iwata, Takeo Saito, Shigeki Yamad. Effectiveness of Clozapine on Employment Outcomes in Treatment-Resistant Schizophrenia: A Retrospective Bidirectional Mirror-Image Study. Neuropsychiatric disease and treatment. vol 19. 2023-03-22. PMID:36945253. |
clozapine is more effective than other antipsychotics and is the only antipsychotic approved for treatment-resistant schizophrenia. |
2023-03-22 |
2023-08-14 |
Not clear |
| Ahmad Srour, Yassin Eltorki, Humayun Malik, Majid A Alabdulla, Mohamed H M O Hassan, Maha Ahmed Al Subaiey, Peter Michael Hadda. Patients' and primary carers' views on clozapine treatment for schizophrenia: A cross-sectional study in Qatar. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society. vol 31. issue 2. 2023-03-21. PMID:36942276. |
patients' and primary carers' views on clozapine treatment for schizophrenia: a cross-sectional study in qatar. |
2023-03-21 |
2023-08-14 |
human |
| Ahmad Srour, Yassin Eltorki, Humayun Malik, Majid A Alabdulla, Mohamed H M O Hassan, Maha Ahmed Al Subaiey, Peter Michael Hadda. Patients' and primary carers' views on clozapine treatment for schizophrenia: A cross-sectional study in Qatar. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society. vol 31. issue 2. 2023-03-21. PMID:36942276. |
subjective views of clozapine treatment among patients with schizophrenia in the middle east and north african mena region have not previously been assessed. |
2023-03-21 |
2023-08-14 |
human |
| Arisa Tsurue, Hideki Funahashi, Keiichi Tsurue, Masahiko Kawano, Yasushi Ishida, Yoji Hiran. A case study of the utilization of clozapine treatment for treatment-resistant schizophrenia associated with 22q11.2 deletion syndrome. Neuropsychopharmacology reports. 2023-03-17. PMID:36929244. |
a case study of the utilization of clozapine treatment for treatment-resistant schizophrenia associated with 22q11.2 deletion syndrome. |
2023-03-17 |
2023-08-14 |
human |
| C Okhuijsen-Pfeifer, M Z van der Horst, J J Luyk. [Towards personalized treatment with clozapine]. Tijdschrift voor psychiatrie. vol 65. issue 2. 2023-03-13. PMID:36912056. |
clozapine is the most effective treatment for people with treatment-resistant schizophrenia. |
2023-03-13 |
2023-08-14 |
Not clear |
| Solveig Sæther Jensen, Jakob Christensen, Biger Johnsen, Simon Hjerril. Ugeskrift for laeger. vol 185. issue 9. 2023-03-10. PMID:36896614. |
this case report presents a 28-year-old female with schizophrenia in clozapine treatment developing ncse twice after two different series of ect treatment. |
2023-03-10 |
2023-08-14 |
Not clear |
| Somdatta Saha, Javier González-Maes. The crosstalk between 5-HT Neuropharmacology. 2023-03-08. PMID:36889432. |
first generation or typical such as haloperidol and second generation or atypical such as clozapine and risperidone remain the current standard for schizophrenia treatment. |
2023-03-08 |
2023-08-14 |
Not clear |
| Fernando Facal, Javier Costa. Polygenic risk scores for schizophrenia and treatment resistance: New data, systematic review and meta-analysis. Schizophrenia research. vol 252. 2023-02-28. PMID:36657363. |
although treatment-resistant schizophrenia (trs) is an important and frequent problem with a specific treatment, clozapine, its biological determinants are poorly understood. |
2023-02-28 |
2024-03-16 |
Not clear |
| Jan P A M Bogers, Peter F J Schulte, Theo G Broekman, Lieuwe de Haa. Feasibility and Effect of Increasing Clozapine Plasma Levels in Long-Stay Patients With Treatment-Resistant Schizophrenia. Journal of clinical psychopharmacology. 2023-02-24. PMID:36825865. |
feasibility and effect of increasing clozapine plasma levels in long-stay patients with treatment-resistant schizophrenia. |
2023-02-24 |
2023-08-14 |
Not clear |
| Jan P A M Bogers, Peter F J Schulte, Theo G Broekman, Lieuwe de Haa. Feasibility and Effect of Increasing Clozapine Plasma Levels in Long-Stay Patients With Treatment-Resistant Schizophrenia. Journal of clinical psychopharmacology. 2023-02-24. PMID:36825865. |
it is unknown whether increasing the clozapine plasma level to 400, 750, or even 1000 ng/ml is a feasible and effective strategy in patients with treatment-resistant schizophrenia (trs). |
2023-02-24 |
2023-08-14 |
Not clear |
| Miriam Olivola, Vincenzo Arienti, Nicola Bassetti, Gianluca Giovanna, Natascia Brondin. Lurasidone Augmentation of Clozapine in Refractory Schizophrenia: A Case Series. Journal of clinical psychopharmacology. 2023-02-24. PMID:36825872. |
lurasidone augmentation of clozapine in refractory schizophrenia: a case series. |
2023-02-24 |
2023-08-14 |
Not clear |